Don't Buy the Move in Drugs and Food Stocks

Taking any cue from stocks day to day in this market -- as opposed to week to week -- has become an idiot's delight. The overall trend can be described as worldwide depression sprinkled with either short-covering bouncebacks or hopes, repeatedly faded -- like the futures -- on government actions.

But I am finding this move today in some of the drug stocks and food stocks very powerful and somewhat compelling given my view that the economy is just awful. I am seeing Schering-Plough (SGP - commentary - Cramer's Take) knocked back to Vytorin-gives-you-cancer levels, yet I don't sense a new series of articles on it. Procter (PG - commentary - Cramer's Take) and Pepsi (PEP - commentary - Cramer's Take) are down, and I just bought some Johnson & Johnson (JNJ - commentary - Cramer's Take) after a big pullback.

Clearly people -- or at least some people -- are betting that the worst is over.

I think that's nonsense. I think the hedge funds oversold certain stocks and people were shooting against the hedgies in a time-honored fashion.

My take? When we get rate cuts, people will sell these stocks, and that's what we are seeing, some pre-selling ahead of rate cuts next week. I say find one you like and get ready to buy it.

Random musings: Interesting piece by Tony Crescenzi about rate cut possibilities. I think they are a given and Ben -- totally irrelevant and wrong -- will act because of our trading partners. He's still worried about inflation. Maybe also about his job. He should be.

At the time of publication, Cramer was long Johnson & Johnson, Pepsi and Procter & Gamble.

ALL JIM CRAMER BLOG ENTRIES | POST A COMMENT | READ COMMENTS  

---

Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here.

TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com.